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Abstract
Most couples enrolled in Assisted Reproductive Technologies’ (ART) treatments need to make decisions regarding
embryo disposition, as they are asked to sign a consent form about embryo donation for research. Beyond the
current assessment of patients’ individual experiences and levels of satisfaction with care delivery, we argue that it
is crucial to provide stakeholders in health systems with feedback on patients’ views about legal and regulatory
frameworks. Such knowledge will lend credence and robustness to the consent that the couples give, and will
contribute to the implementation of informed relational ethics in clinical practice and to improved patient-centredness
in the field of ART.
Background
The legal and regulatory landscape on human embryo
research varies among countries [1]. Taking into account
the 58 countries with coherent data on national policies
or guidelines regarding research on human embryos in
three main sources of information [2–4], 22 countries
ban such research, and 19 countries only allow research
with surplus in vitro fertilization (IVF) embryos, prohi-
biting the creation of embryos only for research pur-
poses. Six countries permit the creation of human
embryos for research aims, four allow research only on
imported embryos and the remaining seven countries
have no legislation on human embryo research.
In countries permitting research on human embryos,
Assisted Reproductive Technologies’ (ART) organizations
and practitioners are increasingly being required to obtain
consent from the woman and the man stating that their
embryos can be used in scientific studies [4–6]. Thus, most
couples enrolled in ART treatments need to make deci-
sions regarding embryo disposition, as they are asked to
sign a consent form about embryo donation for research.
Evidence has consistently shown that this is a complex
and difficult decision-making process, involving several
stages and patient preferences that can change over time
[7–10]. The paper from Aviad Raz and colleagues, which
was recently published in the IJHPR, provides an
extended approach to the understanding of the attitudes,
values and perceptions of IVF patients who decided to
donate cryopreserved embryos to research, based on in-
depth interviews with patients from an IVF unit in Israel
[11]. In accordance with previous studies, that paper
shows how decision-making about embryo donation for
research is influenced by two main iterative and dynamic
dimensions: patients’ hierarchical structuring of the pos-
sible options regarding embryo disposition, framed on
patients’ beliefs about what should be done (considering
for example that it is better to donate than waste the
embryos) [8, 12]; and patients’ representations about the
moral, social and instrumental status attributed to em-
bryos, as for example, considering the embryo as a child
or a life [8, 13] or as a valuable resource that did not yet
have a human identity [11]. It also highlights how regu-
lations constrain individuals’ choices.
We call for a renewed debate on embryo donation for
research that goes beyond the current assessment of pa-
tients’ individual experiences and levels of satisfaction
with care delivery [14, 15]. This debate should also re-
flect on the analysis of real circumstances under which
decisions about embryo disposition are being made - in-
cluding psychosocial and reproductive factors, and struc-
tural drivers (such as norms and values within society;
global and national economic and sociolegal policy; pro-
cesses of governance at the global, national, and local
level; and health care system characteristics) [16]. With
the purpose of enriching patient-centredness in embryo
donation for research, this commentary will discuss two
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main issues regarding patients’ views about legal and
regulatory frameworks. The first issue concerns the
circumstances under which informed consent should be
delivered, explained and signed, considering that pa-
tients’ attitudes about embryo disposition evolve over
time. The second issue concerns the patients’ percep-
tions about storage limits for embryos, taking into ac-
count that they may shape decision-making on embryo
disposition and that there is no evidence justifying the
current storage periods.
Timing set to obtain consent
There are differences between countries regarding
whether the informed consent forms regarding embryo
donation for research should be signed prior to the first
treatment [17], during treatment [18] or after treatment
is completed [19]. Evidence showing changes in couples’
willingness to donate embryos for research supports the
idea of a two/three-stage process to obtain full informed
consent [9, 10, 20]. It also reinforces the argument that
it should be signed only after the infertility treatment is
completed, as recommended by the Ethics Committee of
the American Society for Reproductive Medicine [19].
There is a wide debate about the meaning of informed
consent and what is needed to guarantee its legitimacy
and validity [21, 22], in a context where the relationship
between freedom of action and choice, on the one
hand, and the influence of medical expertise and ad-
vice, and the social context, on the other, emerge as an
important topic of reflection [22]. Overall, it is import-
ant that the consent is effectively informed (which re-
quires an understanding of its content as well the
comprehension of the oral and written information
provided), voluntary (without any pressure or coercion,
external or internal, concerning decision-making) and
reflected (preceded by time to think about the deci-
sion) [5, 23, 24]. These elements are especially relevant
when the decision process involves the search for con-
sensus among partners [25].
Silva et al. [26], for example, also discuss the condi-
tions under which informed, voluntary and reflected
consent is conceptualized and implemented. They have
suggested that informed consent should not be seen as
the result of a purely rational and autonomous process
of decision-making, based on a deep assessment and un-
derstanding of the information provided by health pro-
fessionals, as it is also guided by feelings of trust in these
professionals [22]. Interactions and relationships can
enhance, as well as restrict, the autonomy to consent [27].
Consent is regarded as a perceived and experienced
process constructed through interactions between individ-
uals and their social contexts, where emotions, desires
and feelings shape patients’ responses and decision-
making. It is conceived as an ongoing process rather than
as a discrete act of choice taking place in a given moment
of time [20], which calls attention to the importance of be-
ing revocable at any time.
The process of informed consent may constitute an
opportunity for humanization, democratization, account-
ability and transparency of processes and decisions [19,
28] concerned with ART by fostering dialogue and trust
between health professionals and patients [29, 30] and
providing a space for reflecting about cryopreservation
and decision-making regarding embryo donation for re-
search. However, it can also be reduced to a formality
that may be guided by legitimate medical strategies to
manage risks, expectations and responsibilities in the
field of ART [30, 31].
Thus, attention must be drawn to the need to promote
an in-depth analysis of the clinical, social and political
contexts that influence the consent process [21], in-
cluding the relational and interactional aspects [22],
the changes over time due to fluctuations in the infor-
mation exchanged with the health professionals, and
variations in the social networks or in the reproductive
trajectories of patients [9, 20]. The responsibility of
scientific and medical institutions, health professionals
and researchers regarding the provision of accurate
and timely information that is attentive, responsive,
and tailored to patients’ needs should be highlighted,
in a context where a decrease in patients’ willingness
to donate embryos for research over time is being ob-
served [10, 20]. Investment in information provision is
especially important, taking into account that the ma-
jority of patients highlighted feelings of trust and reci-
procity towards the health professionals who contacted
with them, as well as confidence in the medical and
scientific institutions.
Length of embryo storage
There are regulatory differences regarding the maximum
length of time for embryo storage worldwide [32], which
may influence cross-border reproductive care services
[33, 34]. Embryo storage limits are 3 years in Portugal,
5 years in Denmark, Egypt or Norway and 10 years in
Austria, Australia or Taiwan [4]. It can be longer in
some countries, such as the United Kingdom, where a
maximum storage period of 55 years is available [35],
and it is unlimited in Canada and Finland [4].
The establishment of a storage limit for embryos, up
to now, has relied mostly on social and political criteria
[36, 37]. In fact, the impact of long-term storage on chil-
dren’s and parents’ health and well-being is still poorly
known [38]. Additionally, evidence consistently shows
that the storage length does not detract from the quality
of cryopreserved embryos [38, 39]. In this context, know-
ledge about patients’ views regarding the embryo storage
limit is necessary [32].
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Guidelines to regulate applications to extend embryo
storage should have more flexibility and sensitivity to
take into account the life conditions of patients and their
reproductive trajectories [32]. Moreover, gaps and mis-
conceptions in awareness of cryopreservation were
found, suggesting that more information should be pro-
vided to patients concerning embryo cryopreservation,
and namely about the storage periods [32, 40]. In this
context, the provision of accurate and adequate informa-
tion regarding policies on embryo storage and the devel-
opment of consensual guidelines on storage limits may
help raise awareness about cryopreservation among pa-
tients and also health professionals.
Conclusions
It is now widely recognized that high quality infertility
care comprises more than just the effectiveness of care
[41, 42] and should be patient-centred [43–45]. However,
existing studies adopting a patient-centred approach do
not explore the specific process of decision-making about
embryo disposition, and in particular regarding embryo
donation for research. Knowledge of patients’ perspectives
and experiences with regard to embryo donation for re-
search is essential for the conceptualization of patient-
centred policies and for ethics in clinical practice at the
following levels:
 To analyse openness and information about research
with human embryos;
 To sustain stakeholders’ decisions regarding the
suitability of research projects using cryopreserved
embryos; and
 To disseminate ethically robust evidence to inform
policies and guidelines on embryo cryopreservation
and embryo disposition, namely concerning the
informed consent implementation on a two/three-stage
process [9, 10, 20], and the establishment of storage
periods and the reasons for limitations in these periods
[32], in a context where the views of the patients apply
across legal and political boundaries.
Thus, this commentary calls for a renewed debate that
includes the views of patients about the legal and regula-
tory contexts that frame the clinical practice.
Further research needs to be carried out regarding the
meanings attributed by IVF couples to the possibility of
visualizing their cryopreserved embryos and how these
meanings influence decision-making on embryo dona-
tion for research. The opinions of IVF patients about
what should happen when there is no agreement be-
tween partners concerning embryo disposition needs to
be assessed. Listening to clinic staff perspectives and ex-
periences is required to achieve an integrated view about
the human and system factors that influence patient-
centred care. It is also crucial to analyse egg and sperm
donors’ perspectives on legal and regulatory frameworks
as well as the donors’ real-world decisions about the dis-
position of the embryos resulting from their own gametes.
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